Scriba, Peter Christian; Beckers, C.; Bürgi, H.; Escobar del Rey, F.; Gembicki, M.; Koutras, D. A.; Lamberg, B. A.; Langer, P.; Lazarus, J. H.; Querido, A.; Thilly, C.; Vigneri, R.
Goitre and Iodine Deficiency in Europe.
In: The Lancet, Vol. 325, Nr. 8441: S. 1289-1293
The prevalence of endemic iodine-deficiency goitre in Europe has been reduced in many areas by the introduction of iodination programmes. Recent reports, however, show that goitre remains a significant problem and that its prevalence has not decreased in a number of European countries. Hetzel1 has pointed out that the high global prevalence of iodine-deficiency disorders could be eradicated within 5-10 years by introduction of an iodised salt programme. The current World Health Organisation recommendations for iodine intake are between 150 and 300 μg/day